Subtype-specific intracellular trafficking of alpha(2)-adrenergic receptors

被引:175
作者
Daunt, DA
Hurt, C
Hein, L
Kallio, J
Feng, F
Kobilka, BK
机构
[1] STANFORD UNIV,BECKMAN CTR B159,DEPT CELLULAR & MOL PHYSIOL,STANFORD,CA 94305
[2] UNIV WURZBURG,INST PHARMAKOL,D-97078 WURZBURG,GERMANY
[3] UNIV TURKU,DEPT PHARMACOL & CLIN PHARMACOL,MEDICITY RES LAB,FIN-20520 TURKU,FINLAND
[4] STANFORD UNIV,DEPT CELLULAR & MOL PHYSIOL,HOWARD HUGHES MED INST,STANFORD,CA 94305
[5] STANFORD UNIV,DIV CARDIOVASC MED,STANFORD,CA 94305
关键词
D O I
10.1124/mol.51.5.711
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The three alpha(2)-adrenergic receptor subtypes (alpha(2a), alpha(2b), and alpha(2c)) are highly homologous G protein-coupled receptors. These receptors all couple to pertussis toxin sensitive G proteins and have relatively similar pharmacological properties. To further explore functional differences between these receptors, we used immunocytochemical techniques to compare the ability of the three alpha(2)-receptor subtypes to undergo agonist-mediated internalization. The alpha(2a)-receptor does not internalize after agonist treatment. In contrast, we observed that the alpha(2b)-receptor is able to undergo agonist-induced internalization and seems to follow the same endosomal pathway used by the beta(2)-adrenergic receptor, Attempts to examine internalization of the alpha(2c)-receptor were complicated by the fact that the majority of the alpha(2c)-receptor resides in the endoplasmic reticulum and cis/medial Golgi and there is relatively little cell surface localization. Nevertheless, we were able to detect some internalization of the alpha(2c)-receptor after prolonged agonist treatment. However, we observed no significant movement of alpha(2c)-receptor from the intracellular pool to the plasma membrane during a 4-hr treatment of cells with cycloheximide, suggesting that these cells are unable to process alpha(2c)-receptors in the same way they process the alpha(2a) or alpha(2b) subtypes.
引用
收藏
页码:711 / 720
页数:10
相关论文
共 25 条
[2]  
BYLUND DB, 1988, J PHARMACOL EXP THER, V245, P600
[3]  
COTECCHIA S, 1990, J BIOL CHEM, V265, P63
[4]  
COUPRY I, 1992, J BIOL CHEM, V267, P9852
[5]  
DUZIC E, 1992, J BIOL CHEM, V267, P9844
[6]  
DUZIC E, 1992, J BIOL CHEM, V267, P24045
[7]  
EASON MG, 1992, J BIOL CHEM, V267, P15795
[8]   4 CONSECUTIVE SERINES IN THE 3RD INTRACELLULAR LOOP ARE THE SITES FOR BETA-ADRENERGIC-RECEPTOR KINASE-MEDIATED PHOSPHORYLATION AND DESENSITIZATION OF THE ALPHA(2A)-ADRENERGIC RECEPTOR [J].
EASON, MG ;
MOREIRA, SP ;
LIGGETT, SB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (09) :4681-4688
[9]   THE PALMITOYLATED CYSTEINE OF THE CYTOPLASMIC TAIL OF ALPHA(2A)-ADRENERGIC RECEPTORS CONFERS SUBTYPE-SPECIFIC AGONIST-PROMOTED DOWN-REGULATION [J].
EASON, MG ;
JACINTO, MT ;
THEISS, CT ;
LIGGETT, SB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) :11178-11182
[10]  
EASON MG, 1994, MOL PHARMACOL, V45, P696